Rachel Sachs, associate professor of law
The question of prescription drug pricing and affordability has assumed far greater salience for American patients over the last several years.
One in four Americans report that they have trouble affording their prescriptions, leading them to skip doses or delay filling a prescription entirely. And although health care in general remains quite polarized politically, there is far more agreement on prescription drug pricing: Eighty percent of Americans believe that prescription drug prices are too high, and drug pricing may be one of the few potential areas of bipartisan compromise in the currently divided U.S. Congress.
In short, it is safe to say that consideration of the future of health care in the United States must involve serious consideration of prescription drug pricing.
Read the full piece in The Regulatory Review.
Comments and respectful dialogue are encouraged, but content will be moderated. Please, no personal attacks, obscenity or profanity, selling of commercial products, or endorsements of political candidates or positions. We reserve the right to remove any inappropriate comments. We also cannot address individual medical concerns or provide medical advice in this forum.